Antioxidant effects of statins by modulating Nrf2 and Nrf2/HO-1 signaling in different diseases

A Mansouri, Ž Reiner, M Ruscica… - Journal of Clinical …, 2022 - mdpi.com
Statins are competitive inhibitors of hydroxymethylglutaryl-CoA (HMG-CoA) reductase and
have been used to treat elevated low-density lipoprotein cholesterol (LDL-C) for almost four …

An overview on nanoplatforms for statins delivery: Perspective study for safe and effective therapy methods

L Etemad, Z Salmasi, SAM Kalat, M Moshiri… - Environmental …, 2023 - Elsevier
Statins are the most widely used pharmacological agents for reducing blood cholesterol
levels and treating atherosclerotic cardiovascular diseases. Most of the statins' derivatives …

Statin use in COVID-19 hospitalized patients and outcomes: a retrospective study

H Kouhpeikar, H Khosaravizade Tabasi… - Frontiers in …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) might affect everyone, but people with
comorbidities such as hypertension and cardiovascular disease (CVD) may often have more …

Statins block mammalian target of rapamycin pathway: A possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

NA Lashgari, NM Roudsari, SST Zadeh, S Momtaz… - …, 2023 - Springer
Inflammation plays a critical role in several diseases such as cancer, gastric, heart and
nervous system diseases. Data suggest that the activation of mammalian target of rapamycin …

Paradoxical effects of statins on endothelial and cancer cells: The impact of concentrations

Y Ahmadi, JK Fard, D Ghafoor, AH Eid… - Cancer Cell …, 2023 - Springer
In addition to their lipid-lowering functions, statins elicit additional pleiotropic effects on
apoptosis, angiogenesis, inflammation, senescence, and oxidative stress. Many of these …

[Retracted] The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta‐Analysis

T Jamialahmadi, F Baratzadeh, Ž Reiner… - Oxidative medicine …, 2022 - Wiley Online Library
Background. Elevated serum low‐density lipoproteins (LDL), the substrate for the formation
of atherogenic oxidized LDLs (oxLDL), are a causal factor for atherosclerotic cardiovascular …

Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions

A Tajbakhsh, SM Gheibihayat, H Askari… - Pharmacology & …, 2022 - Elsevier
Efferocytosis (clearance of apoptotic cells by phagocytosis without inducing inflammation
and autoimmunity) is an important mechanism in the resolution of inflammatory processes …

Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension

E Mirhadi, P Kesharwani, TP Johnston… - Drug Discovery Today, 2023 - Elsevier
Highlights•Nanomedicine has emerged as a field with great opportunities to improve
treatment strategies.•Pulmonary arterial hypertension (PAH) is a serious and incurable …

[HTML][HTML] Effect of statins on abdominal aortic aneurysm

A Hosseini, T Sahranavard, Ž Reiner… - European Journal of …, 2022 - Elsevier
Abdominal aortic aneurysm (AAA) is a prevalent condition which causes progressive growth
and rupture of aortic wall with a high death rate. Several studies have found that treatment …

Regulatory effects of statins on SIRT1 and other sirtuins in cardiovascular diseases

D Khayatan, SM Razavi, ZN Arab, M Khanahmadi… - Life, 2022 - mdpi.com
Adverse cardiovascular disease (CVD) outcomes, such as sudden cardiac death, acute
myocardial infarction, and stroke, are often catastrophic. Statins are frequently used to …